Showing results (1161-1170 of 1,708) with videos related to
Sort By:
Pageof 171
Biochemical and Biophysical Research Communications|January 26, 2020
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertensionBiswajit Chowdhury, Albert Z Luu, Vincent Z Luu, et al.Journal of Patient Safety|March 18, 2021
Transmitting Device Identifiers of Implants From the Point of Care to Insurers: A Demonstration ProjectDan C Krupka, Jove Graham, Natalia A Wilson, et al.Journal of the American College of Cardiology|October 8, 2021
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the WeekAlexander E Sullivan, Michael G Nanna, Tracy Y Wang, et al.Stroke and Vascular Neurology|February 2, 2021
Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivorsMark R Etherton, Shreyansh Shah, Xu Haolin, et al.JAMA Cardiology|June 20, 2019
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled TrialsRenato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.Critical Pathways in Cardiology|July 30, 2013
Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient CareBenjamin A Steinberg, Philip D Beckley, Thomas F Deering, et al.Journal of the American College of Cardiology|November 16, 2017
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI RegistryAvinainder Singh, Bradley L Collins, Ankur Gupta, et al.JACC. Cardiovascular Interventions|December 7, 2019
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial SubanalysisJurrien M Ten Berg, Anne de Veer, Jonas Oldgren, et al.Circulation|January 15, 2016
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) TrialMichelle L O'Donoghue, Deepak L Bhatt, Gregg W Stone, et al.Circulation|November 1, 2017
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic AtherosclerosisIlaria Cavallari, David A Morrow, Mark A Creager, et al.Pageof 171